These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16256959)

  • 1. CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited.
    Jardinaud F; Crété D; Canestrelli C; Ledent C; Roques BP; Noble F
    Brain Res; 2005 Nov; 1063(1):77-83. PubMed ID: 16256959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment.
    Cordonnier L; Sanchez M; Roques BP; Noble F
    Neuroscience; 2005; 135(1):1-10. PubMed ID: 16084652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.
    Nieto MM; Guen SL; Kieffer BL; Roques BP; Noble F
    Neuroscience; 2005; 135(2):305-13. PubMed ID: 16112476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.
    Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J
    Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
    Touriño C; Ledent C; Maldonado R; Valverde O
    Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
    Sain NM; Liang A; Kane SA; Urban MO
    Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
    Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
    Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission.
    Mikics E; Vas J; Aliczki M; Halasz J; Haller J
    Behav Pharmacol; 2009 May; 20(3):265-72. PubMed ID: 19421027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of effects of mu-, delta-, and kappa-opioid agonists and enkephalinase inhibitor RB101 in rats of two inbred strains].
    Sudakov SK; Liupina IuV; Medvedeva OF; Tiurina IV; Maldonado R
    Biull Eksp Biol Med; 1998 May; 125(5):551-4. PubMed ID: 9644557
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential regulation of morphine antinociceptive effects by endogenous enkephalinergic system in the forebrain of mice.
    Chen TC; Cheng YY; Sun WZ; Shyu BC
    Mol Pain; 2008 Sep; 4():41. PubMed ID: 18826595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of fear extinction by midbrain periaqueductal gray infusions of RB101(S), an inhibitor of enkephalin-degrading enzymes.
    McNally GP
    Behav Neurosci; 2005 Dec; 119(6):1672-7. PubMed ID: 16420170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CB1 cannabinoid receptors in emotional behaviour.
    Martin M; Ledent C; Parmentier M; Maldonado R; Valverde O
    Psychopharmacology (Berl); 2002 Feb; 159(4):379-87. PubMed ID: 11823890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of the novel cannabinoid full agonist AM 411.
    McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RB101-mediated protection of endogenous opioids: potential therapeutic utility?
    Jutkiewicz EM
    CNS Drug Rev; 2007; 13(2):192-205. PubMed ID: 17627672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
    Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hormonal stress reactivity by the endogenous opioid system.
    Bilkei-Gorzo A; Racz I; Michel K; Mauer D; Zimmer A; Klingmüller D; Zimmer A
    Psychoneuroendocrinology; 2008 May; 33(4):425-36. PubMed ID: 18280051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.